Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA (vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 (COVID-19), but it is not clear whether this RNAemia reflects viremia (ie, virus particles) and how it relates to host immune responses and outcomes.
Methods: SARS-CoV-2 vRNA was quantified in plasma samples from observational cohorts of 51 COVID-19 patients including 9 outpatients, 19 hospitalized (non-intensive care unit [ICU]), and 23 ICU patients. vRNA levels were compared with cross-sectional indices of COVID-19 severity and prospective clinical outcomes. We used multiple imaging methods to visualize virions in plasma.
Results: SARS-CoV-2 vRNA was detected in plasma of 100%, 52.6%, and 11.1% of ICU, non-ICU, and outpatients, respectively. Virions were detected in plasma pellets using electron tomography and immunostaining. Plasma vRNA levels were significantly higher in ICU > non-ICU > outpatients (P < .0001); for inpatients, plasma vRNA levels were strongly associated with higher World Health Organization (WHO) score at admission (P = .01), maximum WHO score (P = .002), and discharge disposition (P = .004). A plasma vRNA level >6000 copies/mL was strongly associated with mortality (hazard ratio, 10.7). Levels of vRNA were significantly associated with several inflammatory biomarkers (P < .01) but not with plasma neutralizing antibody titers (P = .8).
Conclusions: Visualization of virus particles in plasma indicates that SARS-CoV-2 RNAemia is due, at least in part, to viremia. The levels of SARS-CoV-2 RNAemia correlate strongly with disease severity, patient outcome, and specific inflammatory biomarkers but not with neutralizing antibody titers.
Keywords: 19 outcome; 2 RNAemia; 2 viremia; COVID; CoV; SARS.
【저자키워드】 COVID, CoV, 19 outcome, 2 RNAemia, 2 viremia, SARS., 【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Hospitalized, Mortality, cross-sectional, disease severity, COVID-19 severity, outcome, severe acute respiratory syndrome Coronavirus, discharge, clinical outcomes, ICU, outcomes, Cohort, Viral, Host immune response, Viremia, immune responses, Patient, Visualization, plasma, ICU Patients, WHO, outpatients, Viral RNA, respiratory, Admission, Care, Antibody titers, Neutralizing antibody titer, Inflammatory biomarker, Outpatient, COVID-19 patient, immunostaining, electron tomography, Health Organization, Inpatients, World Health Organization, acute respiratory syndrome, acute respiratory syndrome coronavirus, hazard ratio, neutralizing antibody titers, plasma samples, non-ICU, bloodstream, vRNA, virus particles, host immune responses, virion, virions, plasma sample, significantly, virus particle, indicate, significantly higher, Level, reflect, quantified, pellet, 【제목키워드】 coronavirus 2, clinical,